Medical Director for Drug Testing Labs
Drug testing laboratories operate within one of the most heavily regulated environments in healthcare. Beyond CLIA requirements, many facilities must also navigate DEA regulations, DOT and SAMHSA workplace drug testing standards, and state-specific compliance obligations.
Whether you operate a urine drug screening lab, a confirmatory toxicology laboratory, an occupational health testing facility, or a forensic drug testing operation, having a qualified medical director for drug testing labs is essential for maintaining regulatory compliance and protecting your business.
Medical Director Co. connects drug testing laboratories with experienced physician medical directors who understand this complex landscape, often within 12–24 hours.
Overview
Why Drug Testing Labs Need a Specialized Medical Director
Drug testing laboratories face regulatory challenges that extend far beyond standard laboratory oversight. While CLIA requires a qualified laboratory director to oversee testing operations, many drug testing facilities must also comply with DEA regulations governing controlled substance reference standards and federal workplace drug testing requirements established by the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
A physician who only understands CLIA requirements may not be equipped to address the full scope of drug testing lab compliance obligations. Confirmatory toxicology laboratories using LC-MS/MS or GC-MS methodologies often work with DEA-scheduled analytes that trigger additional registration, storage, documentation, and security requirements. Laboratories participating in federal workplace testing programs must also meet rigorous DOT and SAMHSA standards that govern everything from testing methodologies to reporting procedures.
A qualified CLIA drug testing laboratory director should understand how these overlapping frameworks affect daily operations, quality systems, personnel oversight, and regulatory preparedness. For facilities serving federally regulated employers, a knowledgeable DOT drug testing medical director or SAMHSA-certified lab medical director can help support compliance efforts across multiple agencies. Medical Director Co. specializes in sourcing physicians with direct experience in drug testing, toxicology, and workplace testing environments so laboratories can meet their regulatory responsibilities with confidence.
What Is a Medical Director for a Drug Testing Lab?
A medical director for drug testing labs is a licensed physician (MD or DO) who provides medical and regulatory oversight for laboratory operations. The role is particularly important in drug testing environments, where compliance requirements often extend across multiple federal and state agencies.
In many laboratories, the medical director serves as the CLIA laboratory director, the individual designated under federal regulations to oversee testing quality, laboratory personnel, quality assurance programs, and compliance with applicable laboratory standards. This physician is responsible for helping ensure that testing operations meet regulatory requirements and that laboratory practices support accurate, reliable results.
Beyond CLIA oversight, the medical director often serves as the clinical compliance authority for the laboratory’s drug testing program. This may include reviewing testing policies, advising on result interpretation procedures, supporting quality management initiatives, and helping the laboratory navigate changing regulatory expectations.
For laboratories participating in federally regulated workplace drug testing programs, a Medical Review Officer (MRO) is also required. While the MRO and laboratory director are distinct positions, some physicians hold both qualifications. Medical Director Co. connects laboratories with physicians who have direct experience in toxicology and drug testing operations and can also source MRO-certified physicians when required.
Regulatory Landscape
The Regulatory Landscape for Drug Testing Labs
Drug testing laboratories operate under a unique combination of federal and state oversight. Unlike many other laboratory specialties, these facilities may be accountable to multiple agencies simultaneously, each with its own compliance standards, documentation requirements, and enforcement authority.
CLIA — Clinical Laboratory Improvement Amendments: All drug testing laboratories performing non-waived testing must maintain CLIA certification and designate a qualified laboratory director. Laboratories conducting immunoassay drug screening, confirmatory LC-MS/MS testing, or GC-MS analysis typically perform moderate- or high-complexity testing, requiring a director who meets the qualifications outlined under 42 CFR §493.1443. For drug testing laboratories, CLIA compliance establishes the regulatory foundation but does not encompass all applicable requirements.
DEA — Drug Enforcement Administration: Many toxicology and confirmatory testing laboratories use DEA Schedule I or Schedule II controlled substances as reference standards for calibration and quality control purposes. These laboratories may require appropriate DEA registration, including Schedule I Researcher or Schedule II registration, depending on laboratory activities. A medical director should understand DEA registration obligations, controlled substance handling procedures, inventory controls, security requirements, and record-keeping expectations. Failure to comply with DEA requirements can result in registration loss, enforcement actions, and potential criminal penalties.
DOT/SAMHSA — Federal Workplace Drug Testing: Laboratories serving federally regulated employers under DOT 49 CFR Part 40 must obtain certification through the Department of Health and Human Services’ SAMHSA National Laboratory Certification Program (NLCP). These programs require compliance with federal Mandatory Guidelines that establish specific analyte panels, cutoff thresholds, confirmation procedures, chain-of-custody requirements, and reporting standards. The laboratory’s medical director helps support adherence to these regulatory expectations and overall program compliance.
State Drug Testing Regulations: Many states maintain workplace drug testing laws that impose additional requirements beyond federal regulations. These rules may address chain-of-custody procedures, specimen validity testing, employee protections, reporting requirements, and employer testing policies. Certain states also require separate laboratory licensure for drug testing facilities. Medical Director Co. matches laboratories with physicians who understand the drug testing regulations applicable to the laboratory’s state and the jurisdictions served by its clients.
Urine Drug Screen & Immunoassay Laboratories: Urine drug screening laboratories represent the most common segment of the drug testing market. These facilities often perform immunoassay testing classified as moderate-complexity under CLIA and require a qualified laboratory director who can oversee quality control, cutoff configuration, proficiency testing participation, and chain-of-custody procedures. Medical Director Co. regularly places directors for independent screening laboratories, occupational health testing programs, and multi-site screening operations.
Confirmatory Toxicology Laboratories (LC-MS/MS & GC-MS): Confirmatory toxicology laboratories performing LC-MS/MS or GC-MS testing operate within the high-complexity testing category under CLIA. These facilities require directors who meet the qualification standards established under §493.1443 and possess experience with definitive toxicology testing methodologies. Medical Director Co. specifically evaluates candidates for expertise in analytical toxicology, confirmatory testing validation, DEA compliance requirements, and controlled substance reference standard oversight.
HHS/SAMHSA-Certified Federal Workplace Drug Testing Labs: Laboratories certified through the HHS National Laboratory Certification Program face some of the most rigorous regulatory requirements in the industry. These facilities must comply with HHS Mandatory Guidelines, participate in quarterly proficiency testing cycles, prepare for unannounced inspections, and maintain strict quality management standards. Medical Director Co. sources physicians familiar with SAMHSA certification requirements and the operational realities of federally regulated workplace drug testing programs.
Oral Fluid & Alternative Specimen Drug Testing Labs: Oral fluid drug testing continues to expand, particularly following federal regulatory developments supporting its use in workplace testing programs. Laboratories offering oral fluid testing must address unique analytical validation requirements, specimen collection procedures, and quality control considerations. Medical Director Co. helps these facilities identify medical directors who understand both the clinical and regulatory distinctions between oral fluid testing and traditional urine-based drug testing programs.
Core Responsibilities
Core Responsibilities of a Drug Testing Lab Medical Director
The medical director of a drug testing laboratory carries both the standard responsibilities required of a CLIA laboratory director under §493.1445 and additional oversight obligations unique to drug testing operations. Because these laboratories often operate under CLIA, DEA, DOT, SAMHSA, and state regulatory frameworks simultaneously, the role involves clinical oversight, technical supervision, regulatory compliance management, and quality assurance responsibilities that extend well beyond those of many other laboratory specialties.
Core Responsibilities
CLIA Laboratory Director Duties & Compliance Oversight
As the laboratory director, the physician is responsible for the overall clinical and technical direction of the laboratory as required under CLIA §493.1445. This includes oversight of test method validation and verification, quality management systems, personnel qualifications, competency assessments, standard operating procedure review and approval, and proficiency testing participation. For drug testing laboratories performing high-complexity confirmatory testing using LC-MS/MS or GC-MS methodologies, these responsibilities carry the full requirements of high-complexity CLIA oversight. The director must meet applicable qualification standards and maintain active involvement in the laboratory’s compliance and quality programs.
Drug Testing Protocol Development & Method Oversight
The medical director reviews, develops, and approves the laboratory’s drug testing protocols to ensure they align with applicable regulatory requirements and clinical objectives. This includes oversight of immunoassay screening panel design, confirmatory testing methodologies, analyte-specific cutoff concentrations, specimen validity testing procedures, and result reporting formats. For laboratories participating in federal workplace drug testing programs, protocols must comply with HHS Mandatory Guidelines and related DOT requirements. The medical director approves protocol documentation and helps ensure testing procedures remain consistent with current regulatory standards.
Confirmatory Testing Oversight & Result Interpretation Policy
Drug testing laboratories performing definitive testing rely on confirmatory methods such as LC-MS/MS and GC-MS to verify initially reactive screening results. The medical director oversees validation of these analytical methods, reviews quality control procedures, evaluates calibrator and reference standard practices, and establishes policies governing result interpretation. The director also helps define chain-of-custody requirements and reporting standards that support legally defensible testing outcomes. Because confirmatory drug testing results may be used in employment, legal, regulatory, and clinical settings, strong oversight is essential for maintaining reliability and credibility.
DEA Compliance & Controlled Substance Reference Standard Management
Many toxicology laboratories utilize DEA-scheduled substances as analytical reference standards for calibration and quality control activities. The medical director should understand DEA registration requirements, controlled substance storage protocols, inventory management procedures, record-keeping obligations, and disposal requirements for expired or excess materials. While the physician serving as medical director is not necessarily the DEA registrant, familiarity with DEA compliance expectations helps support appropriate laboratory controls and regulatory preparedness. Effective oversight helps reduce compliance risks associated with controlled substance handling programs.
Proficiency Testing, QC Programs & SAMHSA/HHS Compliance
The medical director plays a central role in managing the laboratory’s proficiency testing and quality control programs. Responsibilities include reviewing proficiency testing performance, attesting to proficiency testing results, overseeing corrective action activities when deficiencies occur, and maintaining required documentation. Laboratories participating in federally regulated workplace drug testing programs must also satisfy additional HHS and SAMHSA proficiency testing requirements, including quarterly testing cycles and performance benchmarks tied to certification status. The director’s attestation of proficiency testing performance represents a formal regulatory responsibility.
Personnel Supervision, Training & Chain of Custody Integrity: Drug testing laboratories depend on properly trained personnel to maintain testing quality and regulatory compliance. The medical director oversees qualification requirements, training programs, competency assessments, and ongoing performance evaluations for laboratory staff. This may include specimen accessioners, screening personnel, and confirmatory testing analysts. The director also supports chain-of-custody training and documentation procedures. Maintaining chain-of-custody integrity is particularly important in drug testing because documentation failures can undermine the legal defensibility of laboratory results during employment disputes, regulatory reviews, or legal proceedings.
MRO Coordination & Medical Review Oversight: For laboratories serving workplace drug testing programs, coordination between the laboratory and the Medical Review Officer (MRO) is an important component of compliance. The laboratory medical director oversees testing operations, quality systems, and laboratory compliance, while the MRO reviews and interprets positive, adulterated, substituted, and invalid results before they are reported to employers. In some organizations, a single physician fulfills both roles. In others, separate physicians serve as laboratory director and MRO. Medical Director Co. can source qualified physicians for either role or provide support for both positions simultaneously.
Types of Labs We Support
Types of Drug Testing Labs We Support
Medical Director Co. works with a wide range of drug testing laboratories, from independent screening facilities to highly regulated federal workplace testing programs. Our physician network includes medical directors with experience across multiple testing methodologies, complexity levels, and regulatory environments.
Urine Drug Screen & Immunoassay Laboratories
Urine drug screening laboratories represent the most common segment of the drug testing market. These facilities often perform immunoassay testing classified as moderate-complexity under CLIA and require a qualified laboratory director who can oversee quality control, cutoff configuration, proficiency testing participation, and chain-of-custody procedures. Medical Director Co. regularly places directors for independent screening laboratories, occupational health testing programs, and multi-site screening operations.
Confirmatory Toxicology Laboratories (LC-MS/MS & GC-MS)
Confirmatory toxicology laboratories performing LC-MS/MS or GC-MS testing operate within the high-complexity testing category under CLIA. These facilities require directors who meet the qualification standards established under §493.1443 and possess experience with definitive toxicology testing methodologies. Medical Director Co. specifically evaluates candidates for expertise in analytical toxicology, confirmatory testing validation, DEA compliance requirements, and controlled substance reference standard oversight.
HHS/SAMHSA-Certified Federal Workplace Drug Testing Labs
Laboratories certified through the HHS National Laboratory Certification Program face some of the most rigorous regulatory requirements in the industry. These facilities must comply with HHS Mandatory Guidelines, participate in quarterly proficiency testing cycles, prepare for unannounced inspections, and maintain strict quality management standards. Medical Director Co. sources physicians familiar with SAMHSA certification requirements and the operational realities of federally regulated workplace drug testing programs.
Oral Fluid & Alternative Specimen Drug Testing Labs
Oral fluid drug testing continues to expand, particularly following federal regulatory developments supporting its use in workplace testing programs. Laboratories offering oral fluid testing must address unique analytical validation requirements, specimen collection procedures, and quality control considerations. Medical Director Co. helps these facilities identify medical directors who understand both the clinical and regulatory distinctions between oral fluid testing and traditional urine-based drug testing programs.
Pain Management & Clinical Toxicology Labs
Clinical toxicology laboratories supporting pain management practices, addiction treatment providers, and behavioral health programs operate in a healthcare-focused testing environment. These laboratories perform both presumptive and definitive testing to assist with medication monitoring and treatment management. Medical directors help establish testing policies, oversee quality programs, and support compliance with CLIA requirements while ensuring laboratory services remain aligned with appropriate clinical use.
Occupational Health & Third-Party Administrator (TPA) Labs
Occupational health laboratories and third-party administrator testing programs often support a diverse mix of employer clients, industries, and regulatory requirements. Many perform both DOT and non-DOT testing and must remain compliant throughout the collection, testing, review, and reporting processes. Medical Director Co. connects these organizations with physicians who understand the broad workplace drug testing landscape and the compliance obligations that accompany employer testing programs.
Medical Director Engagement Models for Drug Testing Labs
Drug testing laboratories vary significantly in size, testing complexity, regulatory exposure, and operational structure. Medical Director Co. offers several engagement models designed to meet CLIA §493.1445 active involvement requirements while supporting the specialized compliance needs of drug testing operations.
Remote Medical Director for Drug Testing Labs
The remote medical director model is the most common arrangement for independent drug testing laboratories. Under this structure, the physician performs oversight responsibilities electronically, including quality control review, proficiency testing evaluation, SOP approval, personnel oversight activities, and regulatory consultation. The director may also review drug testing protocols, confirmatory method validation documentation, and DEA compliance procedures remotely. When properly documented, this model satisfies CLIA requirements while providing laboratories with flexible access to experienced physician oversight.
On-Site or Hybrid Medical Director for High-Volume & SAMHSA Labs
Large-volume toxicology laboratories and HHS/SAMHSA-certified facilities often benefit from a hybrid or on-site medical director arrangement. This model provides greater day-to-day involvement through scheduled site visits, direct interaction with laboratory personnel, review of quality performance metrics, and participation in regulatory readiness activities. For SAMHSA-certified laboratories, visible director engagement can be particularly valuable during inspections and certification reviews where regulatory agencies evaluate leadership involvement.
Interim or Emergency Drug Testing Lab Medical Director
Unexpected medical director departures can place a laboratory at immediate risk of non-compliance and disrupt ongoing operations. Medical Director Co. provides rapid placement services for laboratories requiring an interim medical director for drug testing lab operations or an emergency drug testing lab director replacement. Our physician matching is completed within 12–24 hours, helping laboratories restore compliance while conducting a longer-term search for a permanent director.
How Much Does a Medical Director for a Drug Testing Lab Cost?
The cost of a drug testing laboratory medical director depends on both the complexity of the laboratory’s testing program and the number of regulatory frameworks the physician must oversee. Unlike many laboratory specialties, drug testing facilities often require expertise spanning CLIA, DEA, DOT, SAMHSA, and state-specific regulations, which can influence engagement requirements and physician qualifications.
Factors that commonly affect pricing include:
- CLIA testing complexity level (moderate-complexity immunoassay screening versus high-complexity LC-MS/MS or GC-MS confirmatory testing)
- Whether the laboratory holds or is seeking HHS/SAMHSA certification
- DEA registration involvement and controlled substance oversight responsibilities
- Breadth of the laboratory’s test menu and analyte complexity
- Number of CLIA certificates, testing locations, or states covered
- Required engagement structure (remote, hybrid, or on-site)
- Whether MRO certification or MRO services are needed in addition to laboratory director responsibilities
- Placement urgency and timeline requirements
Medical Director Co. provides customized pricing based on the laboratory’s operational and regulatory needs. Request a personalized quote to determine the most appropriate engagement model for your facility and to ensure your drug testing program remains compliant, defensible, and positioned for long-term success.
How to Hire
How to Hire a Medical Director for a Drug Testing Lab
If you’re evaluating candidates and wondering how to hire a medical director for a drug testing lab, use the checklist below to ensure the physician meets both CLIA requirements and the specialized compliance demands of the drug testing industry.
Confirm Board Certification Requirements
Verify that the physician meets the credentialing standards required for your laboratory’s CLIA complexity level. High-complexity confirmatory laboratories performing LC-MS/MS or GC-MS testing require a director who satisfies the qualification requirements outlined in 42 CFR §493.1443, including applicable board certification and laboratory medicine experience.
Verify State Medical Licensure
Ensure the physician maintains active medical licensure in every state where your laboratory operates under its CLIA certificate. Multi-state laboratories may require directors with multiple active licenses.
Assess Drug Testing Laboratory Experience
Look beyond general laboratory medicine credentials. The physician should understand immunoassay screening, confirmatory toxicology testing, specimen validity testing, chain of custody procedures, and drug testing-specific quality requirements.
Confirm DEA Compliance Familiarity
If your laboratory performs confirmatory testing using DEA-scheduled reference standards, the physician should understand DEA registration requirements, controlled substance inventory procedures, storage protocols, and documentation expectations.
Evaluate DOT and SAMHSA Knowledge
Laboratories serving federally regulated employers should seek candidates familiar with DOT 49 CFR Part 40 requirements, HHS Mandatory Guidelines, proficiency testing expectations, and SAMHSA certification standards.
Determine Whether MRO Certification Is Needed
Assess whether your operation requires Medical Review Officer services. If so, confirm whether the physician already holds MRO certification or can obtain it within your required timeframe. Review professional liability coverage: the physician should maintain malpractice coverage appropriate for laboratory director responsibilities, drug testing oversight activities, and the specific regulatory environment in which the laboratory operates. Medical Director Co. simplifies this process through comprehensive credential verification, regulatory screening, and physician matching.
Review professional liability coverage: The physician should maintain malpractice coverage appropriate for laboratory director responsibilities, drug testing oversight activities, and the specific regulatory environment in which the laboratory operates.
Examine the Medical Director Agreement: Review the proposed agreement carefully. It should clearly define CLIA responsibilities, drug testing protocol oversight obligations, response time expectations, proficiency testing review duties, regulatory support requirements, and off-boarding provisions. Medical Director Co. simplifies this process through comprehensive credential verification, regulatory screening, and physician matching.
Benefits
Benefits of Having a Qualified Medical Director for Your Drug Testing Lab
A qualified medical director provides far more than regulatory sign-off. The right physician serves as the foundation of a legally defensible, multi-regulation-compliant drug testing operation and helps protect the laboratory from compliance gaps, certification issues, and operational risk.
Maintains CLIA Compliance
Maintains CLIA compliance and supports continued eligibility for laboratory operations and applicable billing activities.
DEA Registration Compliance
Provides oversight that supports DEA registration compliance and controlled substance handling programs.
SAMHSA Certification Readiness
Helps maintain SAMHSA certification readiness and preparedness for HHS inspections and audits.
Chain of Custody Integrity
Oversees chain of custody procedures that strengthen the legal defensibility of drug testing results.
Documented Quality Program
Supports a documented quality program that builds confidence among employers, TPAs, occupational health networks, and referral partners.
Reduces Result Challenges
Reduces the likelihood of result challenges arising from improperly validated methods, documentation deficiencies, or quality failures.
Withstands CMS & HHS Inspections
Helps ensure SOPs, validation records, quality documentation, and compliance files withstand CMS surveys, HHS inspections, and state audits.
MRO Coordination Resource
Serves as a physician resource for MRO coordination, complex result interpretation questions, and evolving regulatory requirements. For many laboratories, the medical director represents one of the most important compliance investments they make, helping preserve operational continuity while supporting long-term growth.
Who We Serve
Drug Testing Lab Medical Director Services — Who We Serve
Medical Director Co. supports drug testing laboratories and testing programs at every stage of growth, from startup operations to established multi-state testing networks.
Independent Drug Testing Lab Owners & Operators
Independent laboratory owners often face significant regulatory obligations without dedicated in-house compliance teams. Managing CLIA requirements, DEA considerations, workplace testing regulations, and state-specific rules can quickly become overwhelming. Medical Director Co. helps bridge this gap by connecting operators with experienced physician directors who understand the unique challenges facing standalone drug testing laboratories.
Occupational Health Clinics with In-House Drug Testing
Many occupational health clinics perform pre-employment, random, return-to-duty, and post-accident drug testing as part of their service offerings. Although these organizations may already employ physicians, those providers may not meet laboratory director qualification requirements or wish to assume laboratory oversight responsibilities. Medical Director Co. provides qualified physician directors specifically for the laboratory component of these operations.
Third-Party Administrators (TPAs) & Collection Site Networks
TPAs and collection site networks are increasingly expanding into laboratory testing to create more integrated workplace testing solutions. These organizations must navigate both CLIA laboratory requirements and workplace drug testing regulations. Medical Director Co. sources physicians who understand the intersection of laboratory operations, employer testing programs, and DOT compliance requirements.
Pain Management & Addiction Treatment Facility Labs
Behavioral health providers, addiction treatment centers, and pain management practices frequently operate in-house toxicology laboratories for patient monitoring and medication compliance testing. These facilities require CLIA certification and active laboratory oversight despite serving clinical rather than employment testing purposes. Medical Director Co. places directors familiar with clinical toxicology and healthcare-focused drug testing programs.
New Drug Testing Labs & CLIA Applicants
Many new laboratory founders discover that securing a qualified laboratory director becomes one of the biggest obstacles during startup. A laboratory director is required for CLIA certification and often influences DEA registration and SAMHSA application timelines. Medical Director Co. provides rapid physician matching so new laboratories can keep their launch schedules moving forward.
Common Challenges
Common Challenges for Drug Testing Labs & Solutions
Finding a physician who understands CLIA, DEA, and DOT/SAMHSA simultaneously
Many physicians possess laboratory medicine credentials but have limited exposure to DEA-controlled substance requirements or federal workplace drug testing regulations. Medical Director Co. specifically screens for physicians with experience across all major drug testing regulatory frameworks, helping laboratories secure directors with the breadth of expertise their operations require.
Maintaining SAMHSA certification when a director departs
A sudden laboratory director departure can create significant compliance concerns for SAMHSA-certified facilities. Medical Director Co. specializes in rapid physician placement and can often complete matching within 12–24 hours, helping minimize disruption and reduce certification-related exposure.
Navigating DEA registration requirements for confirmatory testing
Confirmatory toxicology laboratories often face complex DEA obligations involving registration, inventory management, security controls, and documentation. Medical Director Co. connects laboratories with physicians familiar with these requirements so compliance responsibilities receive appropriate oversight.
Chain of custody documentation failures and result challenges
Drug testing results are only as defensible as the documentation supporting them. The medical director helps establish chain-of-custody policies, personnel training standards, and documentation procedures that support reliable and legally defensible testing outcomes.
Expanding from screening to confirmatory testing without the right director credentials
Adding LC-MS/MS or GC-MS testing may elevate a laboratory into the high-complexity category under CLIA. Medical Director Co. evaluates whether existing director qualifications remain appropriate for the expanded test menu and helps identify qualified replacements when necessary.
Why Choose Us
Why Choose Medical Director Co. for Your Drug Testing Lab?
Medical Director Co. is built specifically to solve the unique compliance and physician staffing challenges facing drug testing laboratories.
Drug testing specialization
Drug testing specialization — We source physicians with experience spanning CLIA, DEA, DOT, and SAMHSA requirements, not just general laboratory medicine credentials.
Fast placement timelines
Fast placement timelines — Physician matching is often completed within 12–24 hours, including urgent and SAMHSA-certified laboratory situations.
Nationwide physician network
Nationwide physician network — We support laboratories in all 50 states with physicians holding single-state and multi-state licensure.
Compliance-first vetting
Compliance-first vetting — All candidates are screened for applicable CLIA qualification standards, malpractice coverage, and active laboratory oversight experience.
MRO access when needed
MRO access when needed — We can source MRO-certified physicians for laboratories requiring both laboratory director services and medical review support.
Support beyond placement
Support beyond placement — Our assistance extends to protocol review, proficiency testing attestation workflows, DEA compliance guidance, HHS inspection preparation, and ongoing regulatory awareness. Need a qualified drug testing laboratory medical director fast? Contact Medical Director Co. today to get matched with an experienced physician.
Nationwide Drug Testing Lab Medical Director Coverage
Medical Director Co. places drug testing laboratory medical directors in all 50 states. Matching is based on your laboratory’s CLIA complexity level, state licensure requirements, testing methodology, regulatory obligations, and operational structure.
We support laboratories operating in states with additional laboratory oversight considerations, including: New York, California, Florida, Texas, and Maryland.
- CLIA compliance support across moderate- and high-complexity testing environments
- DEA compliance awareness and controlled substance oversight familiarity
- DOT and SAMHSA regulatory knowledge
- Multi-state physician licensure verification
- Proficiency testing review and attestation support
- Ongoing monitoring of relevant drug testing regulatory developments
States We Serve:
Onboarding Process
The Onboarding Process for Drug Testing Labs
1. Drug Testing Lab Assessment
Medical Director Co. begins with a detailed intake process covering your laboratory’s CLIA complexity classification, testing methodologies, immunoassay and confirmatory test menu, oral fluid testing activities, SAMHSA certification status, DEA registration circumstances, state locations, employer client mix, and any pending inspections, audits, or compliance concerns. This information establishes the foundation for physician matching.
2. Cross-Regulatory Physician Matching
Using the information gathered during intake, we identify physician candidates based on board certification requirements, drug testing laboratory experience, DEA compliance familiarity, DOT and SAMHSA knowledge, MRO certification needs, and active state licensure. Our goal is to match each laboratory with a physician whose experience aligns closely with its testing model and regulatory profile.
3. Credential Verification & Compliance Screening
Before presentation, every physician undergoes credential verification and compliance screening. This process includes review of licensure status, CLIA qualification eligibility, malpractice coverage, laboratory director experience, toxicology background, and familiarity with drug testing regulations relevant to the laboratory’s operations and testing complexity level.
4. Medical Director Agreement Execution
Once a candidate is selected, we facilitate the execution of a formal medical director agreement. The agreement outlines CLIA §493.1445 responsibilities, protocol oversight expectations, proficiency testing review obligations, DEA and SAMHSA compliance involvement, response time commitments, chain-of-custody oversight responsibilities, and MRO coordination requirements where applicable.
5. CLIA Documentation & Protocol Onboarding
The physician is formally designated as the laboratory director and begins a comprehensive review of laboratory documentation. This includes SOPs, quality control programs, proficiency testing records, confirmatory method validations, chain-of-custody procedures, DEA compliance documentation, and SAMHSA-related materials when applicable. Any identified compliance gaps can be addressed promptly.
6. Ongoing Oversight & Multi-Regulatory Support
Following onboarding, we help establish a structured oversight cadence that includes proficiency testing reviews, quality management activities, SOP updates, regulatory monitoring, inspection preparedness efforts, and documentation review. This ongoing support helps laboratories maintain compliance across CLIA, DEA, DOT, SAMHSA, and applicable state regulatory frameworks.
Success Stories
Case Study / Success Story
The testimonials below are representative composites based on common client experiences and are provided for illustrative purposes.
“Our SAMHSA-certified drug testing laboratory lost its laboratory director with only two weeks’ notice, and we had an inspection from the Department of Health and Human Services scheduled shortly afterward. We needed a qualified medical director for drug testing labs who understood Clinical Laboratory Improvement Amendments requirements, federal regulations, quality assurance review procedures, and the responsibilities associated with overseeing a federally certified drug testing program. Medical Director Co. matched us with a board-certified physician experienced in laboratory medicine and workplace drug testing within 18 hours. We maintained regulatory compliance, passed our inspection with no deficiencies, and continued serving employers without interruption.”
— Representative Composite, SAMHSA-Certified Workplace Drug Testing Laboratory
“Our clinical laboratory specialized in immunoassay drug screening but wanted to expand into LC-MS/MS confirmatory testing for non-negative drug test results. Moving into high complexity testing required a laboratory director with expertise in clinical chemistry, forensic toxicology, test validation, quality control, and DEA-related compliance requirements. Medical Director Co. connected us with a licensed physician who had direct experience overseeing confirmatory testing programs and reviewing laboratory results generated from complex toxicology workflows. We completed the transition successfully, strengthened our quality assurance program, and expanded our ability to provide accurate and legally defensible laboratory test results.”
— Representative Composite, Confirmatory Toxicology Laboratory
“Our occupational health network operated multiple collection sites supporting employer drug testing programs across several states. We needed a medical director who understood the entire drug testing process, from specimen collection and chain of custody documentation through laboratory results reporting, Medical Review Officer coordination, and reviewing non-negative test results when a legitimate medical explanation needed to be considered. Medical Director Co. placed an experienced physician with deep knowledge of workplace testing, risk management, and regulatory compliance. The result was stronger documentation practices, improved staff training, greater confidence in the accuracy of our drug test results, and a more defensible testing program for our employer clients.”
— Representative Composite, Occupational Health & Employer Drug Testing Network
FAQs
Frequently Asked Questions
A medical director for a drug testing lab serves as the CLIA laboratory director and holds responsibility for the laboratory’s testing operations, quality systems, and regulatory compliance. In addition to standard CLIA oversight, the director reviews and approves drug testing protocols, confirmatory testing validation, chain of custody procedures, proficiency testing participation, and personnel qualifications. For laboratories handling DEA-controlled reference standards or participating in DOT-regulated workplace testing programs, the director also helps oversee compliance with applicable DEA and DOT/SAMHSA requirements.
Yes. Every CLIA-certified drug testing laboratory must designate a qualified laboratory director. The qualification requirements depend on the complexity of the testing performed. Moderate-complexity immunoassay laboratories have different requirements than high-complexity facilities performing LC-MS/MS or GC-MS confirmation testing. For federally regulated workplace testing laboratories, the laboratory director is also reviewed during HHS National Laboratory Certification Program inspections. Operating without a qualified director may result in a condition-level CLIA deficiency and significant compliance consequences.
No. The laboratory medical director and the Medical Review Officer (MRO) perform different functions. The laboratory director oversees testing operations, quality programs, personnel qualifications, and CLIA compliance. The MRO reviews positive, adulterated, substituted, or invalid results before they are reported to employers under DOT workplace drug testing regulations. Some organizations use one physician for both roles, while others separate the responsibilities. Medical Director Co. can source physicians for either position or both, depending on operational needs.
A qualified drug testing lab medical director should understand three major regulatory frameworks. CLIA governs laboratory operations, personnel, testing quality, and certification requirements. DEA regulations govern the handling, storage, documentation, and disposal of controlled substance reference materials used in confirmatory toxicology testing. DOT and SAMHSA requirements apply to federally regulated workplace drug testing programs operating under 49 CFR Part 40 and HHS Mandatory Guidelines. Many laboratories must also comply with state-specific drug testing and laboratory licensure requirements.
The qualifications depend on the laboratory’s testing complexity. For moderate-complexity drug testing laboratories, the director must meet CLIA’s applicable qualification standards. For laboratories performing high-complexity confirmatory testing through LC-MS/MS or GC-MS methodologies, the director must satisfy the requirements outlined in 42 CFR §493.1443. Many qualified directors hold board certification in clinical pathology, clinical chemistry, or another CMS-recognized specialty. Experience with drug testing operations, chain of custody procedures, DEA requirements, and workplace testing regulations is also highly valuable.
Yes. A remote medical director for a drug testing lab is permitted under CLIA as long as all required responsibilities are actively fulfilled and appropriately documented. Remote directors can review quality control data, approve standard operating procedures, oversee proficiency testing activities, evaluate personnel competency programs, and provide protocol consultation electronically. For SAMHSA-certified laboratories, maintaining documentation that demonstrates active engagement is particularly important because HHS inspectors evaluate director involvement during certification reviews and inspections.
Medical Director Co. typically completes physician matching within 12 to 24 hours. Our nationwide network includes physicians with experience in CLIA laboratory oversight, DEA-controlled substance compliance, confirmatory toxicology testing, workplace drug testing programs, and SAMHSA-regulated laboratory environments. For urgent situations, such as an unexpected director departure, pending inspection, or upcoming certification review, we prioritize rapid placement to help laboratories close compliance gaps as quickly as possible.
In most cases, no. The physician serving as the CLIA laboratory director is typically the same individual identified during HHS National Laboratory Certification Program reviews. However, because the laboratory director is a specifically reviewed position during SAMHSA certification inspections, any change in leadership should be documented and communicated appropriately. Medical Director Co. assists laboratories with onboarding, credential documentation, and transition support to help maintain compliance throughout the certification process.
A sudden director departure creates an immediate compliance concern because CLIA-certified laboratories are required to maintain a qualified laboratory director. For SAMHSA-certified facilities, leadership changes may also affect certification-related documentation and inspection readiness. Medical Director Co. specializes in emergency placements and can often identify qualified physician candidates within 12 to 24 hours. We also assist with credential verification, onboarding documentation, and transition planning to restore compliance as efficiently as possible.
Getting started begins with a brief consultation. We gather information about your laboratory’s CLIA complexity level, testing methodologies, DEA registration status, SAMHSA certification requirements, state locations, and operational goals. Based on that assessment, we identify physicians with relevant drug testing experience and appropriate qualifications for your laboratory. Most clients receive candidate introductions within 12 to 24 hours, after which we help coordinate agreements, onboarding documentation, and implementation.
Need a Medical Director for Your Drug Testing Lab?
Finding the right physician for a drug testing laboratory involves more than satisfying a CLIA requirement. Today’s drug testing labs often operate at the intersection of CLIA regulations, DEA compliance obligations, and DOT/SAMHSA workplace testing standards, creating a level of complexity that requires specialized experience.
Medical Director Co. has built a nationwide physician network specifically for drug testing laboratories and can typically match qualified candidates within 12–24 hours. Whether you operate an immunoassay screening lab, a high-complexity toxicology facility, or a SAMHSA-certified workplace testing program, we connect you with physicians who understand the full regulatory landscape.
Medical Director Co. — Cross-regulatory expertise for drug testing labs, nationwide.
Hire a Medical Director or
Collaborating Physician Today
